Envista Holdings vs West Pharmaceutical Services
Envista Holdings (NVST) and West Pharmaceutical Services (WST) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $3.67B
- Last close
- $22.91
- 12 months
- +19.9%
- Market value
- $28.7B
- Last close
- $390.30
- 12 months
- +51.4%
At a glance
- The biggest part of Envista Holdings's revenue is Specialty Products & Technologies (64%); at West Pharmaceutical Services it is Proprietary Products (81%).
- By market value, West Pharmaceutical Services ($28.7B) is about 7.8 times Envista Holdings ($3.7B).
- Over the last 12 months Envista Holdings's share price moved +19.9% and West Pharmaceutical Services's +51.4%; against the S&P 500 that is +14.2 points and +45.7 points.
- In their last fiscal years Envista Holdings kept 1.7% of revenue as net income and West Pharmaceutical Services 16.1%.
- In the last 90 days insiders reported 0 open-market purchases at Envista Holdings and 0 at West Pharmaceutical Services; members of Congress disclosed 0 trades in Envista Holdings and 0 in West Pharmaceutical Services.
- Next results: Envista Holdings Feb 3, 2027, West Pharmaceutical Services Feb 10, 2027.
How each one makes money: Envista Holdings revenue · West Pharmaceutical Services revenue
Share prices on one chart
Envista Holdings and West Pharmaceutical Services, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Envista Holdings NVSTNYSE · Health Care Supplies | West Pharmaceutical Services WSTNYSE · Health Care Supplies | |
|---|---|---|
| Size and profitability | ||
| Market value | $3.67B | $28.7B |
| Revenue, last fiscal year | $2.72B | $3.07B |
| Net income, last fiscal year | $47M | $494M |
| Net marginNet income as a share of revenue | 1.7% | 16.1% |
| Free cash flow | $230M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
West Pharmaceutical Services against
Common questions
How is Envista Holdings different from West Pharmaceutical Services?
Envista Holdings (NVST) is in Health Care Supplies on NYSE, with $2.72B of revenue in its last fiscal year and a net margin of 1.7%. West Pharmaceutical Services (WST) is in Health Care Supplies on NYSE, with $3.07B of revenue in its last fiscal year and a net margin of 16.1%. The biggest part of Envista Holdings's revenue is Specialty Products & Technologies (64%); at West Pharmaceutical Services it is Proprietary Products (81%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Envista Holdings and West Pharmaceutical Services compare in size?
West Pharmaceutical Services has the larger market value: Envista Holdings $3.67B and West Pharmaceutical Services $28.7B, at the last close.
Whose share price rose more over the last 12 months, NVST or WST?
Over the last 12 months Envista Holdings moved +19.9% and West Pharmaceutical Services +51.4%. Past price moves say nothing about the future.
Which has had more insider buying, Envista Holdings or West Pharmaceutical Services?
Since 2006, Envista Holdings insiders reported 17 open-market purchases against 10 for West Pharmaceutical Services. These are counts of what was filed, not a view on either stock.
Do members of Congress trade NVST or WST?
In the last 12 months, members of Congress disclosed 0 trades in Envista Holdings (NVST) and 0 in West Pharmaceutical Services (WST).
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Envista Holdings pageWest Pharmaceutical Services pageRare insider trades this weekAll comparisons
https://oqro.io/compare/nvst-vs-wst



